204 related articles for article (PubMed ID: 33490167)
1. The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis.
Li C; Xia Z; Li A; Meng J
Ann Transl Med; 2020 Dec; 8(24):1655. PubMed ID: 33490167
[TBL] [Abstract][Full Text] [Related]
2. Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Chen B; Yang C; Dragomir MP; Chi D; Chen W; Horst D; Calin GA; Li Q
Ther Adv Med Oncol; 2022; 14():17588359221111703. PubMed ID: 35860836
[TBL] [Abstract][Full Text] [Related]
3. Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.
Lopes S; Pabst L; Dory A; Klotz M; Gourieux B; Michel B; Mascaux C
Front Immunol; 2023; 14():1070076. PubMed ID: 36776847
[TBL] [Abstract][Full Text] [Related]
4. The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis.
Chang Y; Lin WY; Chang YC; Huang CH; Tzeng HE; Abdul-Lattif E; Wang TH; Tseng TH; Kang YN; Chi KY
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612290
[TBL] [Abstract][Full Text] [Related]
5. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
Front Oncol; 2022; 12():753234. PubMed ID: 35280736
[TBL] [Abstract][Full Text] [Related]
6. The association between proton pump inhibitor use and systemic anti-tumour therapy on survival outcomes in patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.
Wei N; Zheng B; Que W; Zhang J; Liu M
Br J Clin Pharmacol; 2022 Jul; 88(7):3052-3063. PubMed ID: 35165922
[TBL] [Abstract][Full Text] [Related]
7. Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer.
Qin BD; Jiao XD; Zhou XC; Shi B; Wang J; Liu K; Wu Y; Ling Y; Zang YS
Oncoimmunology; 2021; 10(1):1929727. PubMed ID: 34350061
[TBL] [Abstract][Full Text] [Related]
8. Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis.
Dar S; Merza N; Qatani A; Rahim M; Varughese T; Mohammad A; Masood F; Reza FZ; Wan S; Almas T
Ann Med Surg (Lond); 2022 Jun; 78():103752. PubMed ID: 35600176
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Concomitant Proton Pump Inhibitors Therapy on Clinical Outcome of Cancer Patients Treated With Immune Checkpoint Inhibitors: A Meta-analysis.
Cao X; Wang Y; Huang W; Li P; Guo C; Li Y
Am J Clin Oncol; 2023 Apr; 46(4):142-149. PubMed ID: 36872516
[TBL] [Abstract][Full Text] [Related]
10. The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapy.
Li M; Zeng C; Yao J; Ge Y; An G
Int Immunopharmacol; 2020 Nov; 88():106972. PubMed ID: 33182025
[TBL] [Abstract][Full Text] [Related]
11. Effect of Antacid Use on Immune Checkpoint Inhibitors in Advanced Solid Cancer Patients: A Systematic Review and Meta-analysis.
Deng R; Zhang H; Li Y; Shi Y
J Immunother; 2023 Feb-Mar 01; 46(2):43-55. PubMed ID: 36301729
[TBL] [Abstract][Full Text] [Related]
12. The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Hu DH; Wong WC; Zhou JX; Luo J; Cai SW; Zhou H; Tang H
J Oncol; 2022; 2022():1001796. PubMed ID: 35855807
[TBL] [Abstract][Full Text] [Related]
13. Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy.
Zhang L; Chen C; Chai D; Li C; Kuang T; Liu L; Dong K; Deng W; Wang W
Front Pharmacol; 2022; 13():1018411. PubMed ID: 36225582
[No Abstract] [Full Text] [Related]
14. Impact of Proton Pump Inhibitor Use on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Cancer Patients.
Peng K; Chen K; Teply BA; Yee GC; Farazi PA; Lyden ER
Ann Pharmacother; 2022 Apr; 56(4):377-386. PubMed ID: 34282636
[TBL] [Abstract][Full Text] [Related]
15. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis.
Lin WY; Wang SS; Kang YN; Porpiglia AS; Chang Y; Huang CH; Bhimani R; Abdul-Lattif E; Azmat M; Wang TH; Lin YS; Chang YC; Chi KY
Front Pharmacol; 2022; 13():1048980. PubMed ID: 36578549
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors.
Baek YH; Kang EJ; Hong S; Park S; Kim JH; Shin JY
Int J Cancer; 2022 Apr; 150(8):1291-1300. PubMed ID: 34877670
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.
Okuyama Y; Hatakeyama S; Numakura K; Narita T; Tanaka T; Miura Y; Sasaki D; Noro D; Tokui N; Okamoto T; Yamamoto H; Narita S; Yoneyama T; Hashimoto Y; Habuchi T; Ohyama C
BJUI Compass; 2022 Mar; 3(2):154-161. PubMed ID: 35474728
[TBL] [Abstract][Full Text] [Related]
18. How to Choose a Survival Period? The Impact of Antibiotic Use on OS or PFS in NSCLC Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen H; Han KD; He ZJ; Huang YS
Technol Cancer Res Treat; 2021; 20():15330338211033498. PubMed ID: 34323149
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.
Rizzo A; Santoni M; Mollica V; Ricci AD; Calabrò C; Cusmai A; Gadaleta-Caldarola G; Palmiotti G; Massari F
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629263
[TBL] [Abstract][Full Text] [Related]
20. Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis.
Petrelli F; Iaculli A; Signorelli D; Ghidini A; Dottorini L; Perego G; Ghidini M; Zaniboni A; Gori S; Inno A
J Clin Med; 2020 May; 9(5):. PubMed ID: 32414103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
